Roivant Sciences (ROIV) Equity Ratio (2021 - 2025)
Roivant Sciences (ROIV) has disclosed Equity Ratio for 5 consecutive years, with 0.82 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Equity Ratio fell 14.51% year-over-year to 0.82, compared with a TTM value of 0.82 through Dec 2025, down 14.51%, and an annual FY2025 reading of 0.95, up 6.86% over the prior year.
- Equity Ratio was 0.82 for Q4 2025 at Roivant Sciences, down from 0.95 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.96 in Q2 2025 and bottomed at 0.62 in Q2 2023.
- Average Equity Ratio over 5 years is 0.81, with a median of 0.8 recorded in 2021.
- The sharpest move saw Equity Ratio decreased 19.3% in 2022, then soared 45.33% in 2024.
- Year by year, Equity Ratio stood at 0.8 in 2021, then dropped by 19.3% to 0.65 in 2022, then skyrocketed by 38.99% to 0.9 in 2023, then rose by 6.14% to 0.96 in 2024, then fell by 14.51% to 0.82 in 2025.
- Business Quant data shows Equity Ratio for ROIV at 0.82 in Q4 2025, 0.95 in Q3 2025, and 0.96 in Q2 2025.